LoginSignup
10X Genomics logo

10X Genomics Stock

StockStock
ISIN: US88025U1097
Ticker: TXG
US88025U1097
TXG

Price

Frequently asked questions

What is 10X Genomics's market capitalization?

The market capitalization of 10X Genomics is $1.92B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for 10X Genomics?

10X Genomics's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$1.527. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for 10X Genomics's stock?

Currently, 15 analysts cover 10X Genomics's stock, with a consensus target price of $39.23. Analyst ratings provide insights into the stock's expected performance.

What is 10X Genomics's revenue over the trailing twelve months?

Over the trailing twelve months, 10X Genomics reported a revenue of $629.74M.

What is the EBITDA for 10X Genomics?

10X Genomics's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$134.78M. EBITDA measures the company's overall financial performance.

What is the free cash flow of 10X Genomics?

10X Genomics has a free cash flow of $25.04M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of 10X Genomics's stock?

The 5-year beta for 10X Genomics is 1.84. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does 10X Genomics have, and what sector and industry does it belong to?

10X Genomics employs approximately 1,259 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of 10X Genomics's shares?

The free float of 10X Genomics is 103.97M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $1.92B

5Y beta

 1.84

EPS (TTM)

 -$1.527

Free Float

 103.97M

Revenue (TTM)

 $629.74M

EBITDA (TTM)

 -$134.78M

Free Cashflow (TTM)

 $25.04M

Pricing

1D span
$15.47$16.32
52W span
$14.02$57.90

Analyst Ratings

The price target is $39.23 and the stock is covered by 15 analysts.

Buy

9

Hold

5

Sell

1

Information

10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for analyzing biological systems. Its Chromium platform includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Chromium Single Cell Multiome ATAC + Gene Expression, Visium Spatial Gene Expression, and others.

1,259

Biotechnology & Drugs

Health Care

Identifier

ISIN

US88025U1097

Primary Ticker

TXG

Knockouts

Join the conversation
Sign upLogin